Table 2.
Location and peak significance of voxel GM analyses in the substantia innominata using DARTEL‐VBM
| Voxel level (p FWE‐corr) | Extent (k) | t, Z | MNI coordinates (x, y, z) (mm) | |
|---|---|---|---|---|
| Group effects | ||||
| Controls versus AD | 0.03 | 9 | 2.8, 2.7 | 18, 2, −12 |
| 0.04 | 8 | 2.6, 2.6 | −18, 2, −12 | |
| Controls versus DLB | 0.002 | 28 | 3.7, 3.6 | 18, 2, −12 |
| 0.02 | 20 | 2.9, 2.9 | −18, 2, −12 | |
| AD versus DLB | No significant differences | |||
| Regression | ||||
| MMSE | 0.05 | 9 | 2.7, 2.5 | −9, 2, −12 |
| CAF | 0.05 | 36 | −2.7, −2.5 | 14, 3, −12 |
GM, grey matter; DARTEL‐VBM, diffeomorphic anatomical registration through exponentiated lie algebra voxel‐based morphometry; MNI, Montreal Neurological Institute; AD, Alzheimer's disease; DLB, dementia with Lewy bodies; MMSE, mini‐mental state examination; CAF, Clinician Assessment of Fluctuations.
This table depicts the corrected voxel‐level significance (p FWE‐corr), spatial extent (k), t and Z scores and MNI coordinates.